Ignite Creation Date:
2024-05-06 @ 1:49 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01905592
Status:
TERMINATED
Last Update Posted:
2022-11-15
First Post:
2013-07-18
Brief Title:
A Phase III Trial of Niraparib Versus Physicians Choice in HER2 Negative Germline BRCA Mutation-positive Breast Cancer Patients
Sponsor:
Tesaro Inc
Organization:
Tesaro Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Neoplasms |
| Neoplasms Breast |
| Carcinoma of Breast |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
| BRCA1 Gene Mutation |
| BRCA2 Gene Mutation |